HIV Articles
Back
	Weight Gain & Integrase Inhibitors       Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens - (05/07/18)   WEIGHT GAIN AFTER SWITCH FROM EFAVIRENZ-BASED TO INTEGRASE INHIBITOR-BASED REGIMENS - Atripla-to-Integrase Inhibitor Switch Tied to Weight Gain Over 18 Months - Mark Mascolini - (10/09/17)   Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals - (05/07/18)   Dolutegravir and weight gain: an unexpected bothering side effect? - (05/07/18)   Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors - (05/04/18)   Antiretroviral initiation is associated with increased skeletal muscle area and fat content - (08/14/17)           View Older Articles   Back to Top   www.natap.org